Advanced Inhalation Therapies Ltd   Report issue

For profit Phase 3
Founded: Petah Tiqwa Israel (2011)
Status: Acquired by Alkermes (1999)

Organization Overview

First Clinical Trial
2013
NCT01768884
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Advanced Inhalation Research Inc | Advanced Inhalation Therapies Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

nitric oxide (inomax) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchiolitis (Phase 3)

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Mycobacterium Infections, Nontuberculous (Phase 2)

Respiratory Aspiration (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 1